NIH-funded research NIH-funded research

Investigating a new target for treating obesity-related insulin resistance

Official title: TP-R: a novel mediator of obesity-linked insulin resistance in humans

Funded at Omaha VA Medical Center · NIH-11073079 · Data updated 2026-11-12

This study is looking at how a specific molecule and its receptor affect weight gain and how our bodies use insulin, with the goal of finding new ways to help people with obesity improve their health.

More Obesity research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOmaha VA Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startApril 1, 2021
Project endMarch 31, 2026
Funding year2025
NIH project number5I01CX002084-05
Project IDNIH-11073079 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults struggling with obesity and insulin resistance, particularly those with elevated levels of branched chain amino acids.

Less likely to help

Patients who are not affected by obesity or insulin resistance may not benefit from this research.

What this research studies

This research explores the role of thromboxane A2 (TXA2) and its receptor (TP-R) in obesity and insulin resistance. It aims to understand how TP-R influences metabolic pathways, particularly in adipose tissue, which is crucial for fat storage and amino acid metabolism. By studying the effects of TP-R on inflammation and insulin sensitivity, the research seeks to identify potential therapeutic targets for improving metabolic health in individuals with obesity. The study will utilize clinical, biochemical, and molecular methods to gather comprehensive data on these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for obesity-related insulin resistance, improving metabolic health for many patients.

How similar studies have gone: While the specific approach of targeting TP-R is novel, related research has shown promise in understanding the metabolic roles of adipose tissue in insulin resistance.

Where this research is happening

  • Omaha VA Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Viswanathan, Saraswathi — Omaha VA Medical Center
  • Study coordinator: Viswanathan, Saraswathi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.